Simple Screening Tool Assesses Cognitive Impairment Post-COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The covered study in this summary was published on medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaway Patients with post-COVID syndrome have a long-term cognitive impairment that can last for more than 3 months and can … Read more

Most COVID Long-Haulers Suffer Fallout for More Than a Year

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Most COVID-19 long-haulers continue to have brain fog, fatigue and compromised quality of life more than a year after the initial infection, results from the most extensive follow up to date of a group of long COVID patients show. Most patients … Read more

The Anxious Patient Needs Psychosomatic Primary Care

A balance between fear and relaxation is normal. However, mental dispositions and the continuous influence of environmental stimuli can disrupt this balance. A failure in therapy can often conceal unvoiced fears. This article is based on the lecture “State of the Art: Treating Anxiety Disorders” by Christian Albus, MD, director of the Clinic and Polyclinic … Read more

When Words Are Not Enough

Almost 1 year into the pandemic, the day finally came when I could welcome patients back to meet in person. For a little over a decade, I have cared for the mental health of healthcare professionals. After nearly a year of telehealth, one by one I welcomed nurses, physicians, physical therapists, nurse practitioners, pharmacists, social … Read more

Study Provides New Data on Isotretinoin and Psychiatric Effects

The use of isotretinoin to treat acne was not associated with an increase in adverse neuropsychiatric outcomes, compared with the use of oral antibiotics, in a large retrospective cohort study published in the British Journal of Dermatology. Although severe neuropsychiatric effects associated with isotretinoin therapy in patients with acne have been reported, “the evidence base…is … Read more

COVID-19 Accelerated Psych Problems for Critical Care Clinicians

Approximately one third of critical care workers reported some degree of depression, anxiety, or somatic symptoms in the early phase of the COVID-19 pandemic, based on survey results from 939 healthcare professionals. The emotional response of professionals in a critical care setting in the early phase of the COVID-19 pandemic has not been well-studied, write … Read more

Juvenile Fibromyalgia Is Associated With Brain Changes

Juvenile fibromyalgia is associated with reduced volume in one region of the brain, according to a recent study. The findings were similar to those in patients with adult fibromyalgia, which suggest the importance of early diagnosis and treatment. The study was published online January 25 in Arthritis and Rheumatology. Adolescent Brain Development Juvenile fibromyalgia is … Read more

Neurocognitive Sequelae of COVID-19 After Acute Infection

The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The burden of self-reported post-acute symptoms and possible sequelae, particularly fatigue and neurocognitive impairment, remains significant 6 to 12 months after acute, even among young and middle-aged adults after mild acute SARS-CoV-2 infection, … Read more

From COVID to Ukraine, Fighting Crisis Fatigue

In casual conversation these days, you’re likely to hear: “I’m just done with COVID.” The problem is the virus isn’t done with us, yet. Nor is Ukraine inflation, or nuclear threats, to name a few. The statistics 2 years into the pandemic are sobering, or should be. Deaths from COVID-19 in the United States are … Read more